From Tufts University School of Medicine, Center for the Study of Drug Development, Boston, Massachusetts.

Received December 15, 2023; accepted after revision January 21, 2024.

Address correspondence to: Richard I. Shader, MD, Professor Emeritus, Tufts University School of Medicine, Center for the Study of Drug Development, Boston, Massachusetts 02111.